Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
Saturday, December 6, 2008 - 14:56
in Health & Medicine
Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Having either too much or too little interleukin-12 may play a role in the development of many diseases, including some cancers and auto-immune disorders like Crohn's, psoriasis, and rheumatoid arthritis. In turn, modulating interleukin-12 levels could yield new therapies for those conditions.
Read the whole article on Biology News Net
More from Biology News Net
Related
- Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plantsWed, 3 Dec 2008, 12:38:05 EST
- Chronic infection now clearly tied to immune-system proteinThu, 14 May 2009, 14:37:16 EDT
- Research shows treating HIV-AIDS with interleukin-2 is ineffectiveThu, 15 Oct 2009, 19:09:31 EDT
- Depression predicts increases in inflammatory protein linked to heart diseaseMon, 5 Oct 2009, 12:38:53 EDT
- Interleukin-10 a prognostic factor in treatment with autologous melanoma vaccineMon, 7 Jun 2010, 9:59:17 EDT